首页 | 本学科首页   官方微博 | 高级检索  
     

非甾体类抗炎药与心血管事件风险的研究进展
引用本文:张颖娇,张冬颖. 非甾体类抗炎药与心血管事件风险的研究进展[J]. 心血管病学进展, 2014, 0(4): 510-514
作者姓名:张颖娇  张冬颖
作者单位:重庆医科大学附属第一医院心血管内科,重庆400016
摘    要:非甾体类抗炎药是一类广泛用于消炎、镇痛的药物,根据对环氧化酶的选择性不同分为三类,研究发现其对心血管事件有一定的影响。环氧化酶-1选择性抑制剂对心血管疾病有二级预防作用,但一级预防作用尚存争议。大多环氧化酶-2选择性抑制剂增加心血管事件风险,部分尚存争议。非选择性抑制剂大多增加心血管事件风险,少部分则几乎无影响。现拟对非甾体类消炎药与心血管事件风险的研究进展做一综述。

关 键 词:非甾体类消炎药  心血管事件  心肌梗死

Advances in Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Events
ZHANG Yingjiao,ZHANG Dongying. Advances in Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Events[J]. Advances in Cardiovascular Diseases, 2014, 0(4): 510-514
Authors:ZHANG Yingjiao  ZHANG Dongying
Affiliation:(Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China)
Abstract:Nonsteroidal anti-inflammatory drugs are widely used to diminish inflammation and pain. According to the ability to inhibit cyclooxygenase,they are divided into three categories. In recent years,lots of researches find that they have certain effect on cardiovascular events. Cyclooxygenase-1 selective inhibitors play a good role in the secondary prevention in subjects with cardiovascular disease,and are still controversial in primary prevention. Cyclooxygenase-2 selective inhibitors mostly increase the risk of cardiovascular events. Most kinds of non selective cyclooxygenase inhibitors also increase the risk. This view focuses on the research progress of the relationship of nonsteroidal anti-inflammatory drugs and cardiovascular events.
Keywords:nonsteroidal anti-inflammatory drugs  cardiovascular events  myocardial infarction
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号